Frontline PET-Directed Therapy with Brentuximab Vedotin Plus AVD Followed By Nivolumab Consolidation in Patients with Limited Stage Hodgkin Lymphoma
Blood | November 29, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1751-1752
10.1182/blood-2022-159258